Results 301 to 310 of about 1,909,397 (348)
Some of the next articles are maybe not open access.
Veterinary Clinics of North America: Small Animal Practice, 1988
Drug interactions are often the result of complex biochemical, physical, and kinetic factors and may not often be easily predicted or even recognized. Although this article has attempted to point out the more common mechanisms and results of drug interactions, the few interactions that have been documented in small animals are undoubtedly only the tip ...
openaire +2 more sources
Drug interactions are often the result of complex biochemical, physical, and kinetic factors and may not often be easily predicted or even recognized. Although this article has attempted to point out the more common mechanisms and results of drug interactions, the few interactions that have been documented in small animals are undoubtedly only the tip ...
openaire +2 more sources
Drug Interactions in Anesthesia
Current Opinion in Anaesthesiology, 1997Anaesthesia is nowadays seldom accomplished by a single agent because no single agent is able to provide all components of anaesthesia without seriously compromising haemodynamic and/or respiratory function, reducing operating conditions, or postponing postoperative recovery.
openaire +4 more sources
2014
Pharmacokinetic drug-drug interactions occur when the absorption, metabolism, distribution, or elimination of one drug is altered by coadministration of another. Compared with many antimicrobial drugs, the fluoroquinolones cause relatively few pharmacokinetic drug-drug interactions.
Roula B. Qaqish, Ronald E. Polk
openaire +2 more sources
Pharmacokinetic drug-drug interactions occur when the absorption, metabolism, distribution, or elimination of one drug is altered by coadministration of another. Compared with many antimicrobial drugs, the fluoroquinolones cause relatively few pharmacokinetic drug-drug interactions.
Roula B. Qaqish, Ronald E. Polk
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1969
Interference With the Delivery of Drugs to Their Sites of Action An increasing number of mechanisms have been described whereby one drug can modify profoundly the action of another. In some of these interactions, the therapeutic effect of a drug may be blocked when another agent prevents it from reaching the site of its pharmacologic action ...
openaire +2 more sources
Interference With the Delivery of Drugs to Their Sites of Action An increasing number of mechanisms have been described whereby one drug can modify profoundly the action of another. In some of these interactions, the therapeutic effect of a drug may be blocked when another agent prevents it from reaching the site of its pharmacologic action ...
openaire +2 more sources
2018
A drug interaction occurs when the effects of a drug are altered by the effects of another drug, a vaccine, herb, foodstuff, or device. In drug–drug interactions, a precipitant drug increases or reduces the effects of an object drug by pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms.
openaire +2 more sources
A drug interaction occurs when the effects of a drug are altered by the effects of another drug, a vaccine, herb, foodstuff, or device. In drug–drug interactions, a precipitant drug increases or reduces the effects of an object drug by pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms.
openaire +2 more sources
Drug-Drug Interactions with Antipsychotics
CNS Spectrums, 2007Recognizing drug-drug interactions (DDIs) has become increasingly important as the country's demographics have aged, resulting in more complex medication regimens. Budnitz and colleagues highlighted the frequency of adverse drug reactions (ADRs) and the substantial morbidity that results.
openaire +3 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
2004
FDA evidence standards for demonstrating the effectiveness and safety of a new molecular entity (NME) are well evolved and defined by current laws and regulations. However, because only a limited number of patients can be studied during the drug development process, unpredictable adverse events can occur following approval. While serious post-marketing
openaire +2 more sources
FDA evidence standards for demonstrating the effectiveness and safety of a new molecular entity (NME) are well evolved and defined by current laws and regulations. However, because only a limited number of patients can be studied during the drug development process, unpredictable adverse events can occur following approval. While serious post-marketing
openaire +2 more sources